| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 09/08/1993 | EP0558630A1 Retroviral protease inhibitors |
| 09/08/1993 | EP0558603A1 Retroviral protease inhibitors |
| 09/07/1993 | US5242904 Peptide boronic acid inhibitors of trypsin-like proteases |
| 09/07/1993 | US5242903 Enzyme inhibitors |
| 09/07/1993 | CA1322078C Enzyme inhibitors |
| 09/07/1993 | CA1322076C Phosphorus containing peptides |
| 09/07/1993 | CA1322075C Flourine containing renin inhibitors |
| 09/07/1993 | CA1322074C Pharmaceutically useful derivatives of thiazolidine-4- carboxylic acid |
| 09/07/1993 | CA1322073C Thiol-carboxylic acid derivatives |
| 09/02/1993 | WO1993016982A1 Bicyclo[2.2.2.]octane derivatives as cholestocystokinin inhibitors |
| 09/02/1993 | WO1993016710A1 PEPTIDYL DERIVATIVES AS INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME |
| 09/02/1993 | CA2128998A1 Bicyclo¬2.2.2.|octane derivatives as cholestocystokinin inhibitors |
| 09/01/1993 | CN1075713A Production of beta-hydroxyalkylamides |
| 08/31/1993 | US5241049 Neutrophil chemoattractants |
| 08/31/1993 | US5240913 Inhibitors of thrombin |
| 08/31/1993 | CA1321769C Preparation of dipeptides |
| 08/25/1993 | EP0556962A1 Small peptide and pseudopeptide amides inhibiting the proliferation of small-cell and epithelial-cell lung cancer cells |
| 08/25/1993 | EP0556485A1 Method for purifying alpha-L-aspartyl-L-phenylalanine methyl ester |
| 08/25/1993 | EP0556405A1 Pseudopentapeptides with immunomodulating activity |
| 08/25/1993 | EP0556214A1 Process for amplifying nucleic acid |
| 08/25/1993 | EP0483271B1 Peptides containing diamino-glycols as transition-state mimics |
| 08/25/1993 | EP0342215B1 Method of diagnosing blood clots using fibrin-binding proteins |
| 08/24/1993 | US5239078 Matrix metalloprotease inhibitors |
| 08/24/1993 | US5238926 Anti-fungal agents |
| 08/24/1993 | US5238924 Treatment of renal diseases with ace inhibitors |
| 08/24/1993 | US5238923 Amino-substituted heterocycles as renin inhibitors |
| 08/24/1993 | US5238922 Inhibitors of farnesyl protein transferase |
| 08/24/1993 | US5238921 Oligopeptide, angiotensin converting enzyme inhibitors, hypotensive agent, and method for treatment of hypertension |
| 08/24/1993 | CA1321676C Homocyclostatine and cyclostatine containing polypeptides as antihypertensive agents |
| 08/24/1993 | CA1321675C Intensely sweet l-aspartyl-3-(bicycloalkyl)-l-alanine alkyl esters |
| 08/19/1993 | WO1993016375A1 Contrast agents useful for both x-ray and mri |
| 08/19/1993 | WO1993016103A1 Aminoacetylmercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace |
| 08/19/1993 | WO1993015756A1 Inhibitors of thrombosis |
| 08/19/1993 | WO1993013741A3 Inhibition of angiogenesis by synthetic matrix metalloprotease inhibitors |
| 08/19/1993 | CA2129035A1 Contrast agents useful for both x-ray and mri |
| 08/18/1993 | EP0556152A1 Pyridinium derivatives and their use in determining connective tissue disorders in humans and animals |
| 08/18/1993 | EP0555537A2 Endothelin antagonistic substance |
| 08/18/1993 | EP0555479A1 Epoxysuccinamic acid derivative |
| 08/17/1993 | US5236900 Treating Candida infections |
| 08/17/1993 | US5236825 Complexing |
| 08/12/1993 | CA2089247A1 Small peptide and pseudopeptide amides inhibiting the proliferation of small-cell and epithelial-cell lung cancer cells |
| 08/10/1993 | US5234909 Dipeptidic amides derived from glycyl-serine as surfactants or hydrating agents and cosmetic, pharmaceutical or alimentary compositions containing the same |
| 08/10/1993 | CA1321280C Urethane-protected amino acid-n-carboxyanhydrides |
| 08/05/1993 | WO1993015062A1 Opioid diarylmethylpiperazines and piperidines |
| 08/05/1993 | WO1993015059A1 3-phenylureido-azepin-2-ones and -benzazepin-2-ones useful as cholecystokinin antagonists |
| 08/05/1993 | WO1993014779A1 Trypsin inhibitors |
| 08/05/1993 | WO1993014777A1 PEPTIDYL DERIVATIVES AS INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME |
| 08/05/1993 | CA2117367A1 3-phenylureido-azepin-2-ones and benzazepin-2-ones useful as cholecystokinin antagonists |
| 08/04/1993 | CN1074903A Substituted hexahyhdroazepinones and tetrahydrobenzazepinones |
| 08/03/1993 | US5232913 Liver disorders, hepatitis disease |
| 08/03/1993 | CA1320923C Enzyme mediated coupling reactions |
| 08/02/1993 | EP0604552A4 Method of synthesizing diverse collections of oligomers. |
| 08/01/1993 | CA2088396A1 Pyridine derivatives |
| 07/28/1993 | EP0552489A2 Peptide, production and use thereof |
| 07/28/1993 | EP0552247A1 Peptides containing substituted 1,4-diamines as transition-state inserts |
| 07/27/1993 | US5231216 Trans-2-acylaminocyclohexyloxyacyldipeptides in the form of mixtures of diastereoisomers thereof and in the form of pure diasteredisomers, process for the preparation thereof and pharmaceutical compositions containing the same |
| 07/27/1993 | US5231084 ACE inhibitor |
| 07/27/1993 | US5231083 Method for the treatment of cardiac and of vascular hypertrophy and hyperplasia |
| 07/27/1993 | CA1320748C Inclination measuring device and a capsule therefor |
| 07/22/1993 | WO1993014115A1 Synthetic peptides for detoxification of bacterial endotoxins and treatment of septic shock |
| 07/22/1993 | WO1993014114A1 Peptide linkage unit comprising methylene phosphinic acid |
| 07/22/1993 | WO1993014113A1 Peptides with tachykinin antagonist activity |
| 07/22/1993 | WO1993014111A1 Novel compound ustiloxin a or b, or derivative thereof |
| 07/22/1993 | WO1993013788A1 Conjugated peptide derivatives containing an acceptor site for glycosylation and therapeutic uses thereof |
| 07/22/1993 | WO1993013741A2 Inhibition of angiogenesis by synthetic matrix metalloprotease inhibitors |
| 07/22/1993 | CA2127295A1 Peptide linkage unit comprising methylene phosphinic acid |
| 07/22/1993 | CA2123576A1 Synthetic peptides for detoxification of bacterial endotoxins and treatment of septic shock |
| 07/21/1993 | EP0551927A1 Method for the treatment of cardiac insufficiency |
| 07/21/1993 | CN1074438A Antithrombotic agents |
| 07/20/1993 | US5229396 Anti-bacterial azabicyclo quinolone carboxylic acids |
| 07/14/1993 | EP0550930A1 Preparation of oligopeptide or amino acid alkyl ester.HCl salis |
| 07/14/1993 | EP0550450A1 Use of crosslinked crystals as a novel form of enzyme immobilization |
| 07/13/1993 | US5227497 Process for preparing N2 -(1-carboxy-3-phenylpropyl)-L-lysine derivative |
| 07/13/1993 | US5227496 Pyroglutamic acid derivatives as enhancers of learning processes and memory and pharmaceutical compositions comprising same |
| 07/13/1993 | CA1320311C Process for producing dry -l-aspartyl-l-phenylalanine methyl ester |
| 07/13/1993 | CA1320310C 4-aminopyridine derivatives and their acid addition salts |
| 07/08/1993 | WO1993013218A1 Endothelin-antagonizing peptide |
| 07/08/1993 | WO1993013065A1 Proline derivative |
| 07/08/1993 | WO1993012819A1 Protein- and peptide-metal ion pharmaceutical applications |
| 07/08/1993 | WO1993012810A1 Pharmaceutical pentapeptide compositions and methods of use thereof |
| 07/08/1993 | WO1993012139A1 A novel molecule which inhibits neuropeptide tyrosine biological function |
| 07/08/1993 | CA2127275A1 Pharmaceutical pentapeptide compositions and methods of use thereof |
| 07/08/1993 | CA2126212A1 A novel molecule which inhibits neuropeptide tyrosine biological function |
| 07/08/1993 | CA2104952A1 Endothelin-antagonizing peptide |
| 07/07/1993 | EP0549727A1 Carboxylic acid esters of rapamycin |
| 07/06/1993 | US5225591 Process for making 1-cyclopentylalyl amines useful for the synthesis of sweeteners |
| 07/06/1993 | US5225587 Method of producing α-L-aspartyl-L-phenylalanine methyl ester hydrochloride |
| 07/06/1993 | US5225532 Symmetrical bipeptides containing a polyalkylene glycol residue, method of preparation and use in the assay of proteases |
| 07/06/1993 | US5225400 Immunostimulating peptides, a process for their preparation and pharmaceutical compositions containing them |
| 06/30/1993 | EP0548234A1 Cloning of chicken anaemia dna |
| 06/30/1993 | CN1073683A Organic salts of N,N'-diacetyl cystine |
| 06/30/1993 | CN1021436C Process for preparing of absolute stereochemical formula crystallographic compound |
| 06/29/1993 | US5223615 Dipeptide derivatives |
| 06/29/1993 | US5223529 N-phenylamides and medicinal products containing them |
| 06/29/1993 | US5223516 Endopeptidase inhibitors |
| 06/29/1993 | US5223488 Oxidized-type glutathione alkyl ester |
| 06/29/1993 | US5223487 Tri-, tetra-, penta- and hexapeptatides of Asp, Gly, Lys, Ser, Ala and salts |
| 06/29/1993 | CA1319787C Process for producing -l-aspartyl-l-phenylalanine methyl ester having an improved solubility |
| 06/28/1993 | CA2086079A1 Peptide, production and use thereof |
| 06/24/1993 | WO1993012138A1 Compounds and compositions for treating hiv infections |